Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Dimitrios Chondros > Profile

Dimitrios Chondros

Affiliations

Svp, Chief Medical Officer at Halozyme Therapeutics Inc. (HALO), 2019-08-06

Insider Trading: Sales See All

Symbol	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
HALO	$16.70	1,328	$22,177.60	38,584	2019-08-03	Filing
HALO	$16.41	2,536	$41,615.76	31,566	2019-02-03	Filing